Effects of intra-basolateral amygdala administration of rimonabant on nociceptive behaviour and neuronal activity in the presence or absence of contextual fear

European Journal of Pain

Volumn 14, Issue 5, 2010, Pages 487-495

  Roche, Michelle ^a   Johnston, Patrick ^a   Mhuircheartaigh, Orla Ní ^a   Olango, Weredeselam M ^a   Mackie, Kenneth ^b   Finn, David P ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Cannabinoid; cFos; Conditioned fear; Pain; Rimonabant (SR141716A)

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; CANNABINOID 1 RECEPTOR; FORMALDEHYDE; PROTEIN FOS; RIMONABANT;

ANALGESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; AVERSION; CINGULATE GYRUS; CONDITIONING; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG ANTAGONISM; DRUG RECEPTOR BINDING; EVOKED RESPONSE; FEAR; HIPPOCAMPUS; IMMUNOREACTIVITY; INTRABASOLATERAL AMYGDALA ADMINISTRATION; MALE; MEDULLA OBLONGATA; NERVE CELL; NERVE CELL STIMULATION; NOCICEPTION; NONHUMAN; PAIN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CATHETERS, INDWELLING; CELL COUNT; CONDITIONING (PSYCHOLOGY); FEAR; FORMALDEHYDE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MEDULLA OBLONGATA; NEURONS; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PERIAQUEDUCTAL GRAY; PIPERIDINES; PROTO-ONCOGENE PROTEINS C-FOS; PYRAZOLES; RATS; RECEPTORS, CANNABINOID;

EID: 77951878235     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2009.08.009     Document Type: Article

References (54)

1. Aloisi A.M., Zimmermann M., and Herdegen T. Sex-dependent effects of formalin and restraint on c-Fos expression in the septum and hippocampus of the rat. Neuroscience 81 (1997) 951-958
2. Arenos J.D., Musty R.E., and Bucci D.J. Blockade of cannabinoid CB1 receptors alters contextual learning and memory. Eur J Pharmacol 539 (2006) 177-183
3. Azad S.C., Monory K., Marsicano G., Cravatt B.F., Lutz B., Zieglgansberger W., et al. Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling. J Neurosci 24 (2004) 9953-9961
4. Baker K.B., and Kim J.J. Amygdalar lateralization in fear conditioning: evidence for greater involvement of the right amygdala. Behav Neurosci 118 (2004) 15-23
5. Beaulieu P., Bisogno T., Punwar S., Farquhar-Smith W.P., Ambrosino G., Di Marzo V., et al. Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat. Eur J Pharmacol 396 (2000) 85-92
6. Bodor A.L., Katona I., Nyiri G., Mackie K., Ledent C., Hajos N., et al. Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types. J Neurosci 25 (2005) 6845-6856
7. Butler R.K., Rea K., Lang Y., Gavin A.M., and Finn D.P. Endocannabinoid-mediated enhancement of fear-conditioned analgesia in rats: opioid receptor dependency and molecular correlates. Pain 140 (2008) 491-500
8. Cannich A., Wotjak C.T., Kamprath K., Hermann H., Lutz B., and Marsicano G. CB1 cannabinoid receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice. Learn Memory 11 (2004) 625-632
9. Carrive P., Leung P., Harris J., and Paxinos G. Conditioned fear to context is associated with increased Fos expression in the caudal ventrolateral region of the midbrain periaqueductal gray. Neuroscience 78 (1997) 165-177
10. Ceccarelli I., Scaramuzzino A., and Aloisi A.M. Effects of formalin pain on hippocampal c-Fos expression in male and female rats. Pharmacol Biochem Behav 64 (1999) 797-802
11. Connell K., Bolton N., Olsen D., Piomelli D., and Hohmann A.G. Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia. Neurosci Lett 397 (2006) 180-184
12. Costa B., Trovato A.E., Colleoni M., Giagnoni G., Zarini E., and Croci T. Effect of the cannabinoid CB1 receptor antagonist, SR141716, on nociceptive response and nerve demyelination in rodents with chronic constriction injury of the sciatic nerve. Pain 116 (2005) 52-61
13. Davis K.D., Hutchison W.D., Lozano A.M., and Dostrovsky J.O. Altered pain and temperature perception following cingulotomy and capsulotomy in a patient with schizoaffective disorder. Pain 59 (1994) 189-199
14. De Oca B.M., DeCola J.P., Maren S., and Fanselow M.S. Distinct regions of the periaqueductal gray are involved in the acquisition and expression of defensive responses. J Neurosci 18 (1998) 3426-3432
15. De Petrocellis L., Bisogno T., Maccarrone M., Davis J.B., Finazzi-Agro A., and Di Marzo V. The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J Biol Chem 276 16 (2001) 12856-12863
16. Duric V., and McCarson K.E. Hippocampal neurokinin-1 receptor and brain-derived neurotrophic factor gene expression is decreased in rat models of pain and stress. Neuroscience 133 (2005) 999-1006
17. Fanselow M.S., and Kim J.J. Acquisition of contextual Pavlovian fear conditioning is blocked by application of an NMDA receptor antagonist d,l-2-amino-5-phosphonovaleric acid to the basolateral amygdala. Behav Neurosci 108 (1994) 210-212
18. Finn D.P., Jhaveri M.D., Beckett S.R., Roe C.H., Kendall D.A., Marsden C.A., et al. Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats. Neuropharmacology 45 (2003) 594-604
19. Finn D.P., Beckett S.R., Richardson D., Kendall D.A., Marsden C.A., and Chapman V. Evidence for differential modulation of conditioned aversion and fear-conditioned analgesia by CB1 receptors. Eur J Neurosci 20 (2004) 848-852
20. Finn D.P., Jhaveri M.D., Beckett S.R., Madjd A., Kendall D.A., Marsden C.A., et al. Behavioral, central monoaminergic and hypothalamo-pituitary-adrenal axis correlates of fear-conditioned analgesia in rats. Neuroscience 138 (2006) 1309-1317
21. Gao Y.J., Ren W.H., Zhang Y.Q., and Zhao Z.Q. Contributions of the anterior cingulate cortex and amygdala to pain- and fear-conditioned place avoidance in rats. Pain 110 (2004) 343-353
22. Geuze E., Westenberg H.G., Jochims A., de Kloet C.S., Bohus M., Vermetten E., et al. Altered pain processing in veterans with posttraumatic stress disorder. Arch Gen Psychiat 64 (2007) 76-85
23. Gibson H.E., Edwards J.G., Page R.S., Van Hook M.J., and Kauer J.A. TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons. Neuron 57 5 (2008) 746-759
24. Gilbert A.K., and Franklin K.B. GABAergic modulation of descending inhibitory systems from the rostral ventromedial medulla (RVM). Dose-response analysis of nociception and neurological deficits. Pain 90 (2001) 25-36
25. Hasanein P., Parviz M., Keshavarz M., and Javanmardi K. CB1 receptor activation in the basolateral amygdala produces antinociception in animal models of acute and tonic nociception. Clin Exp Pharmacol Physiol 34 (2007) 439-449
26. 2+ signaling and NFAT activation. FASEB J 23 (2009) 183-193 [Epub 2008 August 29]
27. Helmstetter F.J. Stress-induced hypoalgesia and defensive freezing are attenuated by application of diazepam to the amygdala. Pharmacol Biochem Behav 44 (1993) 433-438
28. Hohmann A.G., Suplita R.L., Bolton N.M., Neely M.H., Fegley D., Mangieri R., et al. An endocannabinoid mechanism for stress-induced analgesia. Nature 435 (2005) 1108-1112
29. Johansen J.P., Fields H.L., and Manning B.H. The affective component of pain in rodents: direct evidence for a contribution of the anterior cingulate cortex. Proc Natl Acad Sci USA 98 (2001) 8077-8082
30. Katona I., Rancz E.A., Acsady L., Ledent C., Mackie K., Hajos N., et al. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 21 (2001) 9506-9518
31. Khanna S. Dorsal hippocampus field CA1 pyramidal cell responses to a persistent versus an acute nociceptive stimulus and their septal modulation. Neuroscience 77 (1997) 713-721
32. Lauckner J.E., Jensen J.B., Chen H.Y., Lu H.C., Hille B., and Mackie K. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc Natl Acad Sci USA 105 (2008) 2699-2704
33. Lei L.G., Sun S., Gao Y.J., Zhao Z.Q., and Zhang Y.Q. NMDA receptors in the anterior cingulate cortex mediate pain-related aversion. Exp Neurol 189 (2004) 413-421
34. Lin H.C., Mao S.C., and Gean P.W. Effects of intra-amygdala infusion of CB1 receptor agonists on the reconsolidation of fear-potentiated startle. Learn Memory 13 (2006) 316-321
35. Manning B.H., Martin W.J., and Meng I.D. The rodent amygdala contributes to the production of cannabinoid-induced antinociception. Neuroscience 120 (2003) 1157-1170
36. Marsicano G., Wotjak C.T., Azad S.C., Bisogno T., Rammes G., Cascio M.G., et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature 418 (2002) 530-534
37. Martin W.J., Coffin P.O., Attias E., Balinsky M., Tsou K., and Walker J.M. Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections. Brain Res 822 (1999) 237-242
38. McKenna J.E., and Melzack R. Analgesia produced by lidocaine microinjection into the dentate gyrus. Pain 49 (1992) 105-112
39. McKenna J.E., Blocking Melzack.R., and DA N.M. Receptors in the hippocampal dentate gyrus with AP5 produces analgesia in the formalin pain test. Exp Neurol 172 (2001) 92-99
40. Nakagawa T., Katsuya A., Tanimoto S., Yamamoto J., Yamauchi Y., Minami M., et al. Differential patterns of c-fos mRNA expression in the amygdaloid nuclei induced by chemical somatic and visceral noxious stimuli in rats. Neurosci Lett 344 (2003) 197-200
41. Oh S.H., Imbe H., and Iwai-Liao Y. TMJ inflammation increases Fos expression in the nucleus raphe magnus induced by subsequent formalin injection of the masseter or hindpaw of rats. Okajimas Folia Anat Jpn 83 (2006) 43-52
42. Paxinos G., and Watson C. The rat brain in stereotaxic co-ordinates. 2nd ed. (1986), Academic Press Limited, Elsevier, London
43. Roche M., Commons K.G., Peoples A., and Valentino R.J. Circuitry underlying regulation of the serotonergic system by swim stress. J Neurosci 23 (2003) 970-977
44. Roche M., Diamond M., Kelly J.P., and Finn D.P. In vivo modulation of LPS-induced alterations in brain and peripheral cytokines and HPA axis activity by cannabinoids. J Neuroimmunol 181 (2006) 57-67
45. Roche M., O'Connor E., Diskin C., and Finn D.P. The effect of CB(1) receptor antagonism in the right basolateral amygdala on conditioned fear and associated analgesia in rats. Eur J Neurosci 26 (2007) 2643-2653
46. Roche M., Harkin A., and Kelly J.P. Chronic fluoxetine treatment attenuates stressor-induced changes in temperature, heart rate, and neuronal activation in the olfactory bulbectomized rat. Neuropsychopharmacology 32 (2007) 1312-1320
47. Ryberg E., Larsson N., Sjogren S., Hjorth S., Hermansson N.O., Leonova J., et al. The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 152 (2007) 1092-1101
48. Staton P.C., Hatcher J.P., Walker D.J., Morrison A.D., Shapland E.M., Hughes J.P., et al. The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain. Pain 139 1 (2008) 225-236
49. Suplita R.L., Farthing J.N., Gutierrez T., and Hohmann A.G. Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla. Neuropharmacology 49 (2005) 1201-1209
50. Twillman R.K. Mental disorders in chronic pain patients. J Pain Palliat Care 21 4 (2007) 13-19
51. Vianna D.M., Landeira-Fernandez J., and Brandao M.L. Dorsolateral and ventral regions of the periaqueductal gray matter are involved in distinct types of fear. Neurosci Biobehav Rev 25 (2001) 711-719
52. Walker J.M., Huang S.M., Strangman N.M., Tsou K., and Sanudo-Pena M.C. Pain modulation by release of the endogenous cannabinoid anandamide. Proc Natl Acad Sci USA 96 (1999) 12198-12203
53. Watson G.S., Sufka K.J., and Coderre T.J. Optimal scoring strategies and weights for the formalin test in rats. Pain 70 (1997) 53-58
54. Zanoveli J.M., and Brandao M.L. The dorsal periaqueductal and basolateral amygdala are necessary for the expression of conditioned place avoidance induced by semicarbazide stimulation of the dorsal periaqueductal region. Prog Neuro-Psychopharmacol Biol Psychiat 32 (2008) 1715-1721